Brain Scientific Inc. (BRSF)
OTCMKTS
· Delayed Price · Currency is USD
0.7500
-0.6500 (-46.43%)
Apr 25, 2025, 4:00 PM EDT
Brain Scientific Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2016 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2016 - 2017 |
| Revenue | 0.21 | 0.27 | 0.09 | 0.49 | 0.06 | Upgrade
|
| Revenue Growth (YoY) | -19.26% | 183.72% | -80.85% | 741.81% | - | Upgrade
|
| Cost of Revenue | 0.16 | 0.18 | 0.04 | 0.39 | 0.03 | Upgrade
|
| Gross Profit | 0.05 | 0.08 | 0.05 | 0.1 | 0.02 | Upgrade
|
| Selling, General & Admin | 9.36 | 8.41 | 2.61 | 0.97 | 1.1 | Upgrade
|
| Research & Development | 0.3 | 0.33 | 0.21 | 0.1 | 0.21 | Upgrade
|
| Operating Expenses | 9.66 | 8.74 | 2.82 | 1.07 | 1.31 | Upgrade
|
| Operating Income | -9.61 | -8.66 | -2.77 | -0.97 | -1.29 | Upgrade
|
| Interest Expense | -3.61 | -0.56 | -0.03 | -0.03 | -0.16 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | -0 | - | -0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.58 | 0 | - | 0 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | -11.63 | -9.21 | -2.8 | -1 | -1.43 | Upgrade
|
| Impairment of Goodwill | -0.91 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0 | - | - | Upgrade
|
| Other Unusual Items | 0.2 | 0.11 | - | - | - | Upgrade
|
| Pretax Income | -12.34 | -9.1 | -2.8 | -1 | -1.43 | Upgrade
|
| Income Tax Expense | - | - | - | 0 | - | Upgrade
|
| Net Income | -12.34 | -9.1 | -2.8 | -1 | -1.43 | Upgrade
|
| Net Income to Common | -12.34 | -9.1 | -2.8 | -1 | -1.43 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 162.25% | 15.20% | 39.42% | 54.24% | 1.89% | Upgrade
|
| EPS (Basic) | -12.95 | -25.04 | -8.88 | -4.44 | -9.72 | Upgrade
|
| EPS (Diluted) | -12.95 | -25.04 | -8.88 | -4.44 | -9.72 | Upgrade
|
| Free Cash Flow | -5.97 | -5.93 | -0.96 | -0.86 | -1.11 | Upgrade
|
| Free Cash Flow Per Share | -6.26 | -16.30 | -3.05 | -3.78 | -7.59 | Upgrade
|
| Gross Margin | 25.32% | 31.32% | 53.28% | 20.85% | 41.60% | Upgrade
|
| Operating Margin | -4478.11% | -3257.41% | -2956.83% | -198.32% | -2211.42% | Upgrade
|
| Profit Margin | -5753.00% | -3424.57% | -2992.64% | -205.20% | -2454.01% | Upgrade
|
| Free Cash Flow Margin | -2781.62% | -2229.73% | -1027.11% | -174.92% | -1916.67% | Upgrade
|
| EBITDA | -8.78 | -8.44 | -2.75 | -0.97 | -1.28 | Upgrade
|
| EBITDA Margin | - | - | - | -198.05% | - | Upgrade
|
| D&A For EBITDA | 0.82 | 0.22 | 0.02 | 0 | 0 | Upgrade
|
| EBIT | -9.61 | -8.66 | -2.77 | -0.97 | -1.29 | Upgrade
|
| EBIT Margin | - | - | - | -198.32% | - | Upgrade
|
Updated Mar 31, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.